Elara Logo
Elara-HealthYour pacing diary
Research & methodology

How Elara
interprets evidence.

How we connect pacing research, validated questionnaires and wearable trends — while separating self-documentation from diagnosis, treatment claims and PEM prediction.

Sources made visible
Limits stated explicitly
No stand-alone PEM prediction
Exertion ↔ energy
available energy and personal baseline
Context, not a medical threshold
Energy Envelope
pacing framework
FUNCAP-27
validated questionnaire
HRV
context signal
2026
methodology reviewed

Energy Envelope as a pacing framework

Research by Prof. Leonard Jason and colleagues, DePaul University

The Energy Envelope approach compares perceived available energy with energy expended. Elara uses this idea as a framework for structured self-documentation — not as a diagnostic test or a validated PEM prediction model.

The practical goal is to make personal exertion and recovery patterns easier to review over time. Subjective symptoms and lived experience remain central; wearable data can add context but do not define a safe activity limit.

What the framework is for

Support pacing decisions by making the relationship between available energy, exertion, rest and later symptom changes more explicit.

Pacing quotient

Expended energy relative to available energy

(Expended ÷ Available) × 100

Available energy

The person’s own estimate of available capacity for the period being considered.

Expended energy

The recorded or estimated demand from physical, cognitive, emotional and social activity.

Research reference ranges — not medical cut-offs

The 93 and 120 markers come from the distribution used in Energy Envelope research. They can help explain the quotient historically, but they are not validated individual PEM thresholds or instructions to increase activity.

< 93
Lower quotient
Less recorded exertion relative to estimated available energy. This does not by itself mean that more activity is advisable.
93–120
Middle research range
A descriptive range from the research cohort, not a therapeutic target or a definition of a safe energy envelope.
> 120
Higher quotient
More recorded exertion relative to available energy. The value alone does not predict PEM or determine what should happen next.

The historical 93/120 markers roughly correspond to distribution-based reference points in a study cohort. Elara treats quotient views as self-documentation and context, not as a diagnostic score, medical risk class, or green/red light for activity.

What the Energy Envelope evidence does — and does not — show

Energy Envelope studies found associations between keeping perceived energy expenditure closer to perceived available energy and better functioning or lower symptom burden in people with ME/CFS.

The published studies are relatively small and use self-reported available and expended energy. They support a pacing framework, not a universal biological threshold.

Later analyses suggest that overexertion can be associated with worse outcomes even when a person reports higher available energy.

These studies do not validate Elara, a wearable-derived PEM prediction, or any single quotient as a medical decision rule.

Important distinction

Evidence for an underlying pacing concept is not evidence that a specific app feature is clinically effective. Elara therefore presents the quotient and longitudinal data as self-documentation and context, not as diagnosis, treatment, or a guaranteed warning system.

How Elara adds context

The app combines several information layers rather than treating one score or wearable signal as definitive.

Self-reported symptoms, energy & exertion

The person’s own trajectory remains the primary context.

Structured questionnaires

Validated instruments are shown with their published purpose and scoring limits.

Wearable trends

Heart rate, HRV, sleep and activity can add longitudinal context, but are not diagnostic or reliable stand-alone PEM predictors.

Background literature for the pacing framework

These publications inform the Energy Envelope concept and related pacing questions. They are not clinical validation studies of Elara Health or of a wearable-based PEM prediction system.

Jason, L.A., Brown, M., Brown, A., Evans, M., et al. (2013)

Energy Conservation/Envelope Theory Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Fatigue: Biomedicine, Health & Behavior, 1(1-2): 27-42

O'Connor, K., Sunnquist, M., Nicholson, L., Jason, L.A., et al. (2017)

Energy envelope maintenance among patients with myalgic encephalomyelitis and chronic fatigue syndrome

Chronic Illness, 15(1): 51-60

Goudsmit, E.M., Nijs, J., Jason, L.A., Wallman, K.E. (2012)

Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome

Disability and Rehabilitation, 34(13): 1140-1147

Jason, L., Muldowney, K., Torres-Harding, S. (2008)

The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome

AAOHN Journal, 56(5): 189-195

Brown, M., Khorana, N., Jason, L.A. (2011)

The Role of Changes in Activity as a Function of Perceived Available and Expended Energy

Journal of Clinical Psychology, 67(3): 253-260

What does the Energy Envelope mean in daily life?

From model to practice: how pacing decisions align with available energy.

Open pacing hub
How does PEM relate to over- and underexertion?

Delay, early warning signs, and the link to the energy quotient.

Open PEM hub
Where can I find the underlying research?

The two whitepapers go deeper into Energy Envelope and PEM risk prediction.

Open whitepapers
Which lab values usefully accompany fatigue?

Ferritin, vitamin D, B12, TSH – read in symptom context.

Fatigue lab values
Browse the knowledge hub

Four topic hubs covering ME/CFS, PEM, pacing, and lab values.

Open knowledge
Document in a structured way

Questionnaires provide standardized self-assessment for medical conversations.

Open questionnaires
Use it in the app

Energy Envelope, pacing diary, and symptom tracking directly in daily life.

Download app

Learn More?

See how Elara brings together symptom tracking, pacing, and longitudinal documentation for ME/CFS, PEM, Long COVID, and fibromyalgia.

Last updated: January 2026